Guobang Pharma Ltd.SSE: 605507

(605507)"Guobang Pharma Ltd."Report for Q3 2026

Oct 24, 2026 · Issued by Guobang Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 605507 · Oct 24, 2026

On 6ix: 6ix.com/news/605507guobang-pharma-ltdreport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

View original source (Shanghai Stock Exchange)Guobang Pharma Ltd. on 6ix

Earlier from Guobang Pharma

(605507)"Guobang Pharma Ltd."Announcement on Change of Name and Other Industrial and Commercial Information of the Controlling Shareholder and Completion of Industrial and Commercial Registration ChangesOct 17
(605507)"Guobang Pharma Ltd."Announcement on Progress in Repurchasing SharesOct 9
Announcement on Obtaining New Veterinary Drug Registration Certificate by Wholly-owned SubsidiarySep 30
Announcement on a Wholly-owned Subsidiary's Product DMG-PEG2000 Passing the Joint Review and Approval with Its Formulation by the CDESep 16
Announcement on Convening the 2026 Semi-annual Performance BriefingSep 10

Later from Guobang Pharma

(605507)"Guobang Pharma Ltd."Announcement on Completion of Share Repurchase and Implementation Results of RepurchaseOct 30
(605507)"Guobang Pharma Ltd."Announcement on Share Repurchase Plan through Call Auction and the Repurchase ReportOct 30
(605507)"Guobang Pharma Ltd."Announcement on Initial Repurchase of Shares through Call Auction and Progress of RepurchaseNov 2
(605507)"Guobang Pharma Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share RepurchaseNov 4

All Guobang Pharma news releases

Follow Guobang Pharma into a list and get an email when it puts out news.

Follow Guobang Pharma